Yasmin Dahabreh

Yasmin Dahabreh

Auto-generated profile, based on publicly available information

Yasmin Dahabreh

Department of Medicine, An-Najah National University , Rafidia Street, Nablus P400

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2026 in Oxford Medical Case Reports
Verified
Journal Article
Open access
MAMohammed AbuBaha
Mohammed AbuBaha
HSHossam Salameh
Hossam Salameh
BABara AbuBaha
Bara AbuBaha
YDYasmin Dahabreh
Yasmin Dahabreh
OMOmar Marouf
Omar Marouf
HTHatem M Taha
Hatem M Taha
We report a rare case of Insulin Autoimmune Syndrome in a 35-year-old woman with prior autoimmune features who developed hypoglycemia after an allergic reaction. Diagnosis was confirmed by insulin autoantibodies. Immunosuppressive therapy yielded significant improvement. This case suggests a broader autoimmune process may underlie seemingly isolated IAS presentations.

18 January 2025 in The Journal of Medicine, Law & Public Health
Verified
Journal Article
Open access
PDF file
IDIbrahim Omar Dalabeh
Ibrahim Omar Dalabeh
HSHossam Salameh
Hossam Salameh
YDYasmin Dahabreh
Yasmin Dahabreh
AAAbdallah Ali Suleiman Al-Zayadneh
Abdallah Ali Suleiman Al-Zayadneh
MAMehreen Amir
Mehreen Amir
MDMohammad Omar Hamed Dalabeh
Mohammad Omar Hamed Dalabeh
Background: Low-grade gliomas (LGGs) are slow-growing, World Health Organization Grade I and II tumors that can transform into more aggres-sive malignancies over time. This transformation pre- sents significant challenges in managing the burden of health care. Laser-induced thermal therapy (LITT) has emerged as a promising minimally invasive treat-ment option for LGGs, offering precise tumor ablation with minimal damage to surrounding tissues. Method: This narrative review synthesizes data from relevant studies on the evolution, clinical manifestations, mo-lecular characteristics, and emerging management strategies for LGGs, with a focus on the role of LITT. Results: LITT, a minimally invasive technique, offers targeted tumor ablation with the added benefit of disrupting the blood-brain barrier to enhance drug delivery. Studies have shown that LITT can effectively reduce tumor size and improve survival rates in patients with both primary and recurrent gliomas. However, challenges such as procedure-related complications, including motor deficits and cerebral edema, as well as the need for further research on long-term efficacy, remain. Conclusion: LITT represents a significant advancement in the treatment of LGGs, combining precision and minimal invasiveness. Future studies should focus on optimiz-ing protocols, integrating molecular and genetic in-sights, and assessing long-term outcomes to enhance therapeutic efficacy and patient quality of life.